ArticleBiomedicines2022
Safety and Efficacy of Embolization with Microspheres in Chronic Refractory Inflammatory Shoulder Pain: A Pilot Monocentric Study on 15 Patients.
Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 21 citations in OpenAlex.
- Transarterial embolization in the management of chronic shoulder pain: clinical evidence and emerging therapeutic role.Frontiers in radiology · 2026Review
- Initial Experience of Transarterial Embolization for Shoulder Musculoskeletal Pain Using an Ethiodized Oil-Based Emulsion: A Multicenter Study.Cardiovascular and interventional radiology · 2025Article
- Clinical and Radiological Outcomes of Transarterial Embolization for Adhesive Capsulitis.Korean journal of radiology · 2025Article
- Successful Transarterial Embolisation for Recurrent Subacromial-subdeltoid Bursitis: Case Report.Interventional radiology (Higashimatsuyama-shi (Japan) · 2025Article
- Angioembolization in the management of joint pain: current concepts.Orthopadie (Heidelberg, Germany) · 2024Review
- Challenges and complications and their management of the transarterial microembolization for chronic musculoskeletal pain.European radiology · 2024Review
- ACE in the Hole: Adhesive Capsulitis Embolization for the Treatment of Frozen Shoulder.Cardiovascular and interventional radiology · 2024Article
- Safety and Efficacy of Prestige Coils for Embolization of Vascular Abnormalities: The Embo-Prestige Study.Journal of personalized medicine · 2023Article
- Transcatheter embolisation in chronic musculoskeletal disorders.The British journal of radiology · 2023Review
- A Retrospective Comparison of the Efficacy of Embolization with Imipenem/Cilastatin and Microspheres in the Management of Chronic Shoulder Pain.Cardiovascular and interventional radiology · 2023Article
- Transcatheter Arterial Embolization for Alleviating Chronic Musculoskeletal Pain and Improving Physical Function: A Narrative Review.Diagnostics (Basel, Switzerland) · 2022Review
- Feasibility of Neovessel Embolization in a Large Animal Model of Tendinopathy: Safety and Efficacy of Various Embolization Agents.Journal of personalized medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMusculoskeletal (MSK) embolization is emerging in tendinopathy treatment. The objective of this study was to assess the efficacy and safety of MSK embolization with microspheres in the treatment of chronic shoulder pain. PATIENTS AND
methodsThis retrospective monocentric study included patients with chronic shoulder pain resistant to 6 months or more of conventional therapies who were treated with MSK embolization between 2017 and 2021. Embolization was performed using calibrated 100-250 µm microspheres. Clinical success was defined as pain reduction, i.e., a decrease in the visual analogue scale (VAS) pain score of ≥50% at 3 months after MSK embolization as compared to baseline. Adverse events were collected.
resultsFifteen patients (11 women, 4 men) were included, with a median age of 50.3 years (IQR: 46.7-54.5). The median duration of symptoms was 26.6 months (20.6-39.8). The median VAS pain scores were 7.0 (7.0-8.0) at baseline, 6.0 (3.5-7.0) at 1 month, 5.0 (4.5-6.5) and 5.0 (3.0-7.4) at 3 months and 6 months (
conclusionMSK embolization with microspheres for treatment of refractory chronic shoulder pain showed moderate results in terms of clinical success and safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.